-Receptor antagonists in angina pectoris.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000526:Alprenolol / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D013015:Sotalol / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D010919:Placebos; D013565:Sympatholytics; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol